115654-39-2 Usage
Uses
Used in Pharmaceutical Industry:
(S)-1-CBZ-AMINO-2-BOC-AMINO-4-METHYLPENTANE is used as a key component in the development of new drugs and therapeutic agents. Its unique structure and properties make it a valuable asset in the creation of innovative pharmaceuticals.
Used in Organic Synthesis:
In the field of organic synthesis, (S)-1-CBZ-AMINO-2-BOC-AMINO-4-METHYLPENTANE is used as a versatile building block for constructing complex organic molecules. Its reactivity and functional groups allow for the formation of a wide range of compounds.
Used in Peptide Chemistry:
(S)-1-CBZ-AMINO-2-BOC-AMINO-4-METHYLPENTANE is used as a fundamental unit in peptide chemistry, facilitating the synthesis of peptides with specific functions and properties. Its incorporation into peptide sequences can lead to the development of novel bioactive molecules.
Used in Research and Development:
(S)-1-CBZ-AMINO-2-BOC-AMINO-4-METHYLPENTANE is also utilized in research and development for the creation of new materials and bioconjugates. Its chemical and physical properties make it suitable for exploring new applications and advancing scientific understanding in various fields.
Check Digit Verification of cas no
The CAS Registry Mumber 115654-39-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,1,5,6,5 and 4 respectively; the second part has 2 digits, 3 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 115654-39:
(8*1)+(7*1)+(6*5)+(5*6)+(4*5)+(3*4)+(2*3)+(1*9)=122
122 % 10 = 2
So 115654-39-2 is a valid CAS Registry Number.
InChI:InChI=1/C19H30N2O4/c1-14(2)11-16(21-18(23)25-19(3,4)5)12-20-17(22)24-13-15-9-7-6-8-10-15/h6-10,14,16H,11-13H2,1-5H3,(H,20,22)(H,21,23)/t16-/m0/s1
115654-39-2Relevant academic research and scientific papers
Parallel synthesis of an oligomeric imidazole-4, 5-dicarboxamide library
Xu, Zhigang,DiCesare, John C.,Baures, Paul W.
supporting information; experimental part, p. 248 - 254 (2010/08/19)
A library of oligomeric compounds was synthesized based on the imidazole-4, 5-dicarboxylic acid scaffold along with amino acid esters and chiral diamines derived from amino acids. The final compounds incorporate nonpolar amino acids (Leu, Phe, Trp), polar amino acids (Ser, Asp, Arg), and neutral amino acids (Gly, Ala), and were designed to be useful in screening for inhibitors of protein-protein interactions. Many of the protected and deprotected oligomers show evidence of conformational isomers persistent at room temperature in aqueous solution. A total of 317 final oligomers, out of 441 targeted compounds, were obtained in high analytical purity and of sufficient quantity to submit them for high-throughput screening as part of the NIH Roadmap.
